FANJ
WX

Financial Architects (New Jersey)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Financial Architects (New Jersey)’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-106
Closed -$4K – 1176
2015
Q2 		$4K Hold
106
– – ﹤0.01% 1028
2015
Q1 		$4K Buy
+106
New +$4.08K ﹤0.01% 920

Other funds holding WX

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Financial Architects (New Jersey)'s WX Position: Q3 2015 in Review

Financial Architects (New Jersey) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 106 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in WX in Q1 2015 and held it in 2 quarters. The position peaked at $4K in Q2 2015. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

  • Financial Architects (New Jersey) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 106 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $4K.
  • Financial Architects (New Jersey) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2015 and held it in 2 quarters.
  • Financial Architects (New Jersey)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2015, filed 13 Nov 2015.